Creoptix focuses on next-generation bioanalytical instruments for drug discovery and life sciences for both industry and academic research. Creoptix was acquired by Malvern Panalytical in 2022.
Creoptix focuses on next-generation bioanalytical instruments for drug discovery and life sciences for both industry and academic research. Creoptix was acquired by Malvern Panalytical in 2022.
Zugerstrasse 76, 8820 Wädenswil, Switzerland